Shen YC - Search Results

1

Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessment.

Yeh SP, Liao YM, Hsu CH, Chen CL, Shen YC, Hsueh CT, Huang HH, Chiu CF. Yeh SP, et al. Among authors: shen yc. Am J Clin Pathol. 2004 Dec;122(6):919-25. doi: 10.1309/23DA-L9F6-P74X-WJHL. Am J Clin Pathol. 2004. PMID: 15539384

2

Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis.

Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, Cheng AL. Shen YC, et al. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1986-90. doi: 10.1158/1055-9965.EPI-04-0932. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16103449

3

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT; Taiwan Cooperative Oncology Group. Chen JS, et al. Ann Oncol. 2015 May;26(5):943-949. doi: 10.1093/annonc/mdv035. Epub 2015 Jan 28. Ann Oncol. 2015. PMID: 25632066 Free article. Clinical Trial.

4

Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.

Ou DL, Shen YC, Liang JD, Liou JY, Yu SL, Fan HH, Wang DS, Lu YS, Hsu C, Cheng AL. Ou DL, et al. Among authors: shen yc. Clin Cancer Res. 2009 Sep 15;15(18):5820-8. doi: 10.1158/1078-0432.CCR-08-3294. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737956

5

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.

Shen YC, Liu TH, Nicholas A, Soyama A, Yuan CT, Chen TC, Eguchi S, Yoshizumi T, Itoh S, Nakamura N, Kosaka H, Kaibori M, Ishii T, Hatano E, Ogawa C, Naganuma A, Kakizaki S, Cheng CH, Lin PT, Su YY, Chuang CH, Lu LC, Wu CJ, Wang HW, Rau KM, Hsu CH, Lin SM, Huang YH, Hernandez S, Finn RS, Kudo M, Cheng AL. Shen YC, et al. J Clin Oncol. 2024 Aug 28:JCO2400645. doi: 10.1200/JCO.24.00645. Online ahead of print. J Clin Oncol. 2024. PMID: 39197119

6

Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.

Hsu C, Shen YC, Cheng CC, Hong RL, Chang CJ, Cheng AL. Hsu C, et al. Among authors: shen yc. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):856-61. doi: 10.1158/1055-9965.EPI-05-0821. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702360

7

Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design.

Hsu C, Shen YC, Cheng CC, Hu FC, Cheng AL. Hsu C, et al. Among authors: shen yc. Contemp Clin Trials. 2010 Jan;31(1):55-61. doi: 10.1016/j.cct.2009.08.002. Epub 2009 Sep 6. Contemp Clin Trials. 2010. PMID: 19737631

8

Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung.

Yeh KH, Yeh SH, Wan JP, Shen YC, Cheng AL. Yeh KH, et al. Among authors: shen yc. Anticancer Drugs. 2005 Aug;16(7):739-42. doi: 10.1097/01.cad.0000171769.43940.58. Anticancer Drugs. 2005. PMID: 16027522

9

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.

Hsu CH, Shen YC, Lin ZZ, Chen PJ, Shao YY, Ding YH, Hsu C, Cheng AL. Hsu CH, et al. Among authors: shen yc. J Hepatol. 2010 Jul;53(1):126-31. doi: 10.1016/j.jhep.2010.01.035. Epub 2010 Mar 30. J Hepatol. 2010. PMID: 20416968 Clinical Trial.

10

Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia.

Lin CH, Liau JY, Lu YS, Huang CS, Lee WC, Kuo KT, Shen YC, Kuo SH, Lan C, Liu JM, Kuo WH, Chang KJ, Cheng AL. Lin CH, et al. Among authors: shen yc. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1807-14. doi: 10.1158/1055-9965.EPI-09-0096. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

877 results

Search Page

Filters